Nalaganje...
Efficacy and safety of laquinimod in multiple sclerosis: current status
Laquinimod is a novel immunomodulatory agent, in development as a potential disease-modifying treatment for multiple sclerosis (MS). Structurally related to linomide, its pharmacological predecessor, laquinimod combines anti-inflammatory and possibly clinically relevant neuroprotective effects with...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3825117/ https://ncbi.nlm.nih.gov/pubmed/24228070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285613499424 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|